scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Krebs Biochemicals & Industries Ltd

Feedback
Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd (KREBSBIO) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,654
Mar 20, 2025 15:42 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹77.29
₹2.29 (3.05%)
₹75 Low
Today’s Performance
₹78.7 High
₹60.35 Low
52 Week’s Performance
₹129.07 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 3.05%
  • 1 Week -4.42%
  • 1 Month -12.74%
  • 3 Months -24.28%
  • 6 Months -17.21%
  • 1 Year 16.01%
  • 3 Years -21.58%
  • 5 Years 1.30%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 1.06
  • 52-Week Low (₹) 60.35
  • 52-Week High (₹) 129.07
  • Price-to-Book (X)* -1.27
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* -6.73
  • Earnings Per Share (₹) -11.37
  • Sector Price Earning (X)* 33.64
  • Market Cap (₹ Cr.)* 161.70
  • * Vaues as of last close price

COMPETITORS

BT TV

Akshay Bhagwat: 'Recovery rally, probability looks high 23,500-23,700 should be in making in April' 46:28 Daily Calls LIVE: Ask Your STOCK MARKET TODAY QUERIES | Market Update LIVE | Share Market News Today
U.S. Federal Reserve Warns: Trump's Tariffs Driving Inflation Higher! 2:49 U.S. Federal Reserve Warns: Trump's Tariffs Driving Inflation Higher!
Andhra Pradesh Attracting Top Investors, Ashok Leyland's Game-Changing Move | Nara Lokesh 1:49 Andhra Pradesh Attracting Top Investors, Ashok Leyland's Game-Changing Move | Nara Lokesh
A Must Have Midcap Fund To Boost Returns 10:03 A Must Have Midcap Fund To Boost Returns
Trump Luxury Commercial Project In Pune: A Game Changer For The City's Future 1:08 Trump Luxury Commercial Project In Pune: A Game Changer For The City's Future
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Aug 13, 2021 Sell
BRESCON VENTURES PRIVATE LIMITED
  • Qty 225000
  • Average Price ₹149.07
Dec 28, 2020 Sell
BRESCON VENTURES PRIVATE LIMITED
  • Qty 100000
  • Average Price ₹137.75
Oct 13, 2017 Sell
RACHANADEVI RAJU AGARWAL
  • Qty 91270
  • Average Price ₹90.00
Oct 13, 2017 Sell
RACHANADEVI RAJU AGARWAL
  • Qty 91270
  • Average Price ₹90.00
Jul 02, 2014 Sell
NATIONAL ISURANCE CO LTD
  • Qty 56563
  • Average Price ₹20.02
Jul 02, 2014 Sell
NATIONAL ISURANCE CO LTD
  • Qty 56563
  • Average Price ₹20.02
May 03, 2013 Sell
ANAPOTHANA VEMA TRUST
  • Qty 71730
  • Average Price ₹9.50
May 03, 2013 Sell
ANAPOTHANA VEMA TRUST
  • Qty 71730
  • Average Price ₹9.50
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Krebs Biochemicals & Industries Ltd share price previously?
Krebs Biochemicals & Industries Ltd share price was up by 3.05% from the previous closing price of ₹75.00.
Who are peers of Krebs Biochemicals & Industries Ltd?
The peers of Krebs Biochemicals & Industries Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Krebs Biochemicals & Industries Ltd?
The promotor/promotors of Krebs Biochemicals & Industries Ltd are G V L Prasad, R T Ravi, Avinash Ravi, Tangirala Malati, Satish Khivsara, Raj Kamal Prasad Verma, Jitendra Shah, Keyur Doshi, Popatlal M Kathariya, Dipti Shah, SATYA CHIGURUPATI, Sumanth Karlapudi.
What has been 52-week high of Krebs Biochemicals & Industries Ltd stocks?
The highest price of Krebs Biochemicals & Industries Ltd stock is ₹129.07 in the last 52-week.
What is the share price of Krebs Biochemicals & Industries Ltd (KREBSBIO) today on NSE?
As on Mar 20, 2025, Krebs Biochemicals & Industries Ltd (KREBSBIO)’s share price on NSE is Rs 77.29
What is the market cap of Krebs Biochemicals & Industries Ltd (KREBSBIO?)
The current market capitalisation of Krebs Biochemicals & Industries Ltd (KREBSBIO) is 161.70 crores
What is Krebs Biochemicals & Industries Ltd Share symbol?
The symbol of Krebs Biochemicals & Industries Ltd is KREBSBIO.
What is the PE ratio of Krebs Biochemicals & Industries Ltd (KREBSBIO)?
The current PE ratio of Krebs Biochemicals & Industries Ltd (KREBSBIO) is -6.73.
What is the PB ratio of Krebs Biochemicals & Industries Ltd (KREBSBIO)?
The current PB ratio of Krebs Biochemicals & Industries Ltd (KREBSBIO) is -1.27.
Today’s High & Low share prices of Krebs Biochemicals & Industries Ltd (KREBSBIO) on NSE?
Today, the share price of Krebs Biochemicals & Industries Ltd (KREBSBIO) on NSE touched a high of Rs 78.7 and a low of Rs 75
What price did Krebs Biochemicals & Industries Ltd (KREBSBIO) shares open on the NSE today?
On NSE, the share price of Krebs Biochemicals & Industries Ltd (KREBSBIO) opened at Rs 78.7
What is the 52-week high of Krebs Biochemicals & Industries Ltd (KREBSBIO)?
The 52-week high price of Krebs Biochemicals & Industries Ltd (KREBSBIO) is Rs 129.07
What is the 52-week low of Krebs Biochemicals & Industries Ltd (KREBSBIO) ?
The 52-week low price of Krebs Biochemicals & Industries Ltd (KREBSBIO) is Rs 60.35

ABOUT KREBS BIOCHEM

Krebs Biochemicals & Industries Ltd, incorporated in the year 1991, has its registered office in Kothapalli(V) Kasimkota(M), Anakapalli, Vishakapatnam, Andhra Pradesh, 531031, 91-040-6680 8040. The main industry in which Krebs Biochemicals & Industries Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Krebs Biochemicals & Industries Ltd is/are Bhavani & Co. In the main management, R T Ravi is chairman and Keyur Doshi is the company secretary for Krebs Biochemicals & Industries Ltd.

  • GVLP G V L Prasad Independent Director
  • RTR R T Ravi Chairman (Non-Executive)
  • AR Avinash Ravi Non Executive Director
  • TM Tangirala Malati Independent Director
  • SK Satish Khivsara Independent Director
  • RKPV Raj Kamal Prasad Verma Independent Director
  • JS Jitendra Shah Managing Director & CEO
  • KD Keyur Doshi Company Sec. & Compli. Officer
  • PMK Popatlal M Kathariya Additional Director
  • DS Dipti Shah Additional Director
  • SC SATYA CHIGURUPATI Additional Director
  • SK Sumanth Karlapudi Additional Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement